Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Aftertreated polymer
Reexamination Certificate
2007-06-05
2007-06-05
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Aftertreated polymer
C424S484000, C424S423000, C424S718000
Reexamination Certificate
active
10623239
ABSTRACT:
Extremely hydrophobic nitric oxide (NO) releasing polymers are disclosed. The extremely hydrophobic NO-releasing polymers provided are extensively cross-linked polyamine-derivatized divinylbenzene diazeniumdiolates. These polymers can be loaded with extremely high NO levels and designed to release NO in manners than mimic natural biological systems. The NO-releasing extremely hydrophobic polymers provided can maintain a sustained NO release for periods exceeding nine months. Also provided are related medical devices made using these NO-releasing extremely hydrophobic polymers.
REFERENCES:
patent: 4954526 (1990-09-01), Keefer
patent: 5039705 (1991-08-01), Keefer et al.
patent: 5155137 (1992-10-01), Keefer et al.
patent: 5171217 (1992-12-01), March et al.
patent: 5212204 (1993-05-01), Keefer et al.
patent: 5229172 (1993-07-01), Cahalan et al.
patent: 5250550 (1993-10-01), Keefer et al.
patent: 5268465 (1993-12-01), Bredt et al.
patent: 5366997 (1994-11-01), Keefer et al.
patent: 5380758 (1995-01-01), Stamler et al.
patent: 5405919 (1995-04-01), Keefer et al.
patent: 5428070 (1995-06-01), Cooke et al.
patent: 5468630 (1995-11-01), Billiar et al.
patent: 5482925 (1996-01-01), Hutsell
patent: 5519020 (1996-05-01), Smith et al.
patent: 5525357 (1996-06-01), Keefer et al.
patent: 5574068 (1996-11-01), Stamler et al.
patent: 5583101 (1996-12-01), Stamler et al.
patent: 5632981 (1997-05-01), Saavedra et al.
patent: 5650447 (1997-07-01), Keefer et al.
patent: 5658565 (1997-08-01), Billiar et al.
patent: 5676963 (1997-10-01), Keefer et al.
patent: 5683668 (1997-11-01), Hrabie et al.
patent: 5691423 (1997-11-01), Smith et al.
patent: 5700830 (1997-12-01), Korthuis et al.
patent: 5714511 (1998-02-01), Saavedra et al.
patent: 5718892 (1998-02-01), Keefer et al.
patent: 5721365 (1998-02-01), Keefer et al.
patent: 5770645 (1998-06-01), Stamler et al.
patent: 5789447 (1998-08-01), Wink, Jr. et al.
patent: 5814656 (1998-09-01), Saavedra et al.
patent: 5814667 (1998-09-01), Mitchell et al.
patent: 5837313 (1998-11-01), Ding et al.
patent: 5837736 (1998-11-01), Mitchell et al.
patent: 5840759 (1998-11-01), Mitchell et al.
patent: 5877216 (1999-03-01), Place et al.
patent: 5891459 (1999-04-01), Cooke et al.
patent: 5910316 (1999-06-01), Keefer et al.
patent: 5945452 (1999-08-01), Cooke et al.
patent: 5958427 (1999-09-01), Salzman et al.
patent: 5962520 (1999-10-01), Smith et al.
patent: 5994444 (1999-11-01), Trescony et al.
patent: 6024918 (2000-02-01), Hendriks et al.
patent: 6703046 (2004-03-01), Fitzhugh et al.
patent: WO 00/02501 (2000-01-01), None
patent: WO 0030658 (2000-06-01), None
Pulfer et al. (Incorporation of Nitric Oxide-Releasing Crosslinked polyethyleneimine Microspheres Into Vascular Grafts; Journal of Biomedical Materials Research; Wiley, New York, NY, vol. 37, No. 2, Nov. 1997; pp. 182-189).
Bauer et al.; Evaluation of Linear Polyethyleneimine
itric Oxide Adduct on Wound Repair: Therapy versus Toxicity; Wound Repair & Regeneration, Nov./Dec. 1998, pp. 569/577.
Chandy et al; “Use of Plasma Glow for Surface/Engineering Biomolecules to Enhance Bloodcompatibility of Dacron and PTFE Vascular Prosthesis.” Biomaterials 21:699-712.
Drago; “Free Radicals in Inorganic Chemistry.” No. 36, Advances in Chemistry Series, American chemical society, Washington, D. C. 1962, pp. 143/149.
Hanson et al; Nitric Oxide Donors: A Continuing Opportunity in Drug Design; Advances in Pharmacology, vol. 34, pp. 383/398.
Hrabie et al; “New Nitric Oxide/Releasing Zwitterions Derived from Polyamines.” J. Org. Chem. 1993, 58, 1472/1476.
Jordi; Jordi Gel Columns for Size Exclusion Chromatography; Column Handbook for Size Exclusion Chromatography; 1999, pp. 367/425.
Kaul et al.; Polymeric/Based Perivascular Delivery of a Nitric Oxide Donor Inhibits Intimal Thicening After Balloon Denudation Arterial Injury: Role of Nuclear Factor/kappaB; Journal of the Americna College of Cardiology, vol. 35, No. 2, 2000:493/501.
Keefer et al; “NONOates” (1/Substituted Diazen/I/ium/1,2/diolates) as Nitric Oxide Donors: Convenient Nitric Oxide Dosage Forms. Methods in Enzymology, vol. 268: 281/293.
Mowery et al.; Preparation and Characterization of Hydrophobic Polymeric Films That Are Thromboresistant Via Nitric Oxide Release; Biomaterials 21 (2000) 9/21.
Saavedra et al.; “Conversion of Polysaccharide to Nitric Oxide/Releasing Form Dual/Mechanism Anticoagulant Activity of Diaseniumdiolated Heparin.” Bioorganic & Medicinal Chemistry Letter 10 (2000) 1/3.
Smith et al.; Nitric Oxide/Releasing Polymers Containing the [N(O)NO]Group; J. Med. Chem. 1996, 39, 1148/1156.
Downey et al.; Growth Mechanism of Poly(divinylbenzene) Microspheres in Precipitation Polymerization; American Chemical Society, Easton, US, vol. 32, No. 4, May 4, 1999; pp. 2838-2844.
Pulfer et al.; Incorporation of Nitric Oxide-Releasing Crosslinked Polyethyleneimine Microspheres Into Vascular Grafts; Journal of Biomedical Materials Research; Wiley, New York, NY, vol. 37, No. 2, Nov. 1997; pp. 182-189.
Zhang et al.; Synthesis of Nitric Oxide Releasing Silicone Rubbers for Biomedical Applications; Polymer Preprints; vol. 40, No. 2, 1999, pp. 799-800.
Cafferata Robert
Fitzhugh Anthony L.
Keefer Larry K.
Fubara Blessing
Hartley Michael G.
Medtronic Vascular Inc.
LandOfFree
Highly cross-linked, extremely hydrophobic nitric... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Highly cross-linked, extremely hydrophobic nitric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly cross-linked, extremely hydrophobic nitric... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3883798